Business / Finance

RSS

Bedfont chosen as finalist in 2 categories for KEiBA 2018

The Kent Excellence in Business Awards recognizes companies across Kent and rewards their excellence and achievements.

From Bedfont® Scientific Ltd 5 Jun 2018

Montecito Medical acquires Pinnacle Orthopedics Center in Georgia

Montecito Medical Real Estate, a premier owner of medical office buildings throughout the U.S., has acquired the Pinnacle Orthopedics Center, a Class A medical office and surgery center from a leading orthopedic provider in Woodstock, Georgia, approximately 30-miles north of downtown Atlanta and part of the Atlanta metropolitan area.

10 May 2018

Akili Interactive closes $55 million financing to advance digital medicine platform for treatment of cognitive dysfunction

Akili Interactive, a leading prescription digital medicine company developing novel treatments for cognitive dysfunction, today announced that it has successfully closed a $55 million Series C financing led by Temasek.

9 May 2018

NeuroproteXeon completes distribution agreement with Linde AG

NeuroproteXeon announced today that they have completed a distribution agreement with Linde AG (Lin.de) for XENEX™ (xenon by inhalation) for Post Cardiac Arrest Syndrome ("PCAS") for the European Union plus United Kingdom, Switzerland, Norway and Iceland.

9 May 2018

Broadridge Financial Solutions acquires Ireland-based company, FundAssist

Broadridge Financial Solutions, Inc., a global fintech leader, has completed the acquisition of FundAssist Limited, a regulatory, marketing and sales solutions service provider to the global investments industry.

9 May 2018

Porvair and Finneran appoint new OEM Business Development Manager for microplate product lines

Porvair Sciences and J.G. Finneran Associates are pleased to announce the appointment of Bob Brino as OEM Business Development Manager for their microplate and sample prep product lines.

From Porvair Sciences Limited 9 May 2018

Activinsights celebrates success after winning Britain’s top business accolade

Activinsights – a world leader in delivering lifestyle insights and behavioral data analysis for healthcare professionals – is enjoying success after winning Britain’s top business accolade, the prestigious Queen’s Award for Enterprise in the International Trade category.

9 May 2018

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for the treatment of a variety of seizure disorders.

27 Apr 2018

SpeeDx signs distribution agreement with Serosep to strengthen sales in the UK and Ireland

SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor of laboratory diagnostic solutions. This will strengthen sales channels in the UK and Ireland, ensuring greater access to SpeeDx’s multiplexed PlexPCR and ResistancePlus molecular diagnostic tests across the region.

24 Apr 2018

Aziyo Biologics, BIOTRONIK enter into US co-distribution agreement

Aziyo Biologics, Inc., a fully integrated regenerative medicine company, today announced that it has entered into a US co-distribution agreement for its CanGaroo Bio Envelope with BIOTRONIK, Inc., a global leader in cardio- and endovascular medical technology.

19 Apr 2018

Teva and Procter & Gamble Company terminate PGT Healthcare partnership

Teva Pharmaceutical Industries has announced that Teva and the Procter & Gamble Company have agreed to terminate the PGT Healthcare partnership that the two companies established in 2011 to market OTC (Over The Counter) medicines.

19 Apr 2018

Expedeon relocates to Cambridge as part of integration into SYGNIS Group

SYGNIS AG today announced the completion of the relocation of its subsidiary company, Expedeon, into the Company’s existing facilities in Cambridge, UK.

16 Apr 2018

SYGNIS AG acquires bioconjugation specialist Expedeon

Expedeon, a specialist provider of bioconjugation products and services, has announced it has been fully acquired by Sygnis AG, for EUR 8 million in cash and 3.5 million in shares.

16 Apr 2018

Tradeshow Talks with Analytik Jena

We spoke to Ulrich Krauss, the CEO of Analytik Jena yesterday at analytica 2018.

From Analytik Jena AG 12 Apr 2018

Tradeshow Talks with Synthace

Sean Ward, CTO of Synthace, tells us why they are at Analytica 2018.

10 Apr 2018

New CTX™ X-ray fluorescence elemental analyzer introduced by Bruker at Analytica 2018

Bruker today introduces the new CTX™ X-ray fluorescence (XRF) elemental analyzer. The portable Counter Top XRF (CTX) is small, light-weight, safety-interlocked, and battery operated. At less than 7 kilograms in weight, the self-contained CTX is truly portable, and has a small footprint of 14 cm in width.

From Bruker 10 Apr 2018

New INVENIO™ Fourier Transform Infrared research spectrometer launched by Bruker

Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications.

10 Apr 2018

Oxford Gene Technology announces leadership changes

Oxford Gene Technology, The Molecular Genetics Company, has announced that on 1st April 2018 Dr John Anson who has been with the company since 2006 as EVP of R&D took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT’s board.

From Oxford Gene Technology 10 Apr 2018

Pittcon 2019 committee calls for technical program proposals

The Pittcon Technical Program Committee is now accepting proposals for Symposia, Workshops, and Organized Contributed Sessions for the 2019 Technical Program.

From Pittcon 9 Apr 2018

MILabs reports continuous growth in sales of preclinical imaging systems

MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continued on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close to 50%.

9 Apr 2018